The Role of Early Diagnosis in the Prevention of Polycystic Ovary Syndrome Complications in Women of Reproductive Age

Ravshanova Sevinch¹; Bozorova Shaxrizoda²

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age and is associated with reproductive, metabolic, and psychological complications. The condition is characterized by hormonal imbalance, ovulatory dysfunction, and polycystic ovarian morphology. Delayed diagnosis frequently leads to infertility, menstrual disturbances, insulin resistance, obesity, and cardiovascular complications. Early recognition and management of the disease play a crucial role in reducing long-term adverse outcomes and improving reproductive health. This study aimed to evaluate the importance of early diagnosis in preventing complications associated with polycystic ovary syndrome. The findings demonstrated that timely diagnosis and individualized treatment significantly improve clinical outcomes.

Keywords: polycystic ovary syndrome, reproductive health, infertility, hormonal imbalance, early diagnosis, gynecology, menstrual disorders.

Polycystic ovary syndrome affects a considerable proportion of women worldwide and remains a major public health concern in reproductive medicine. The disorder has a multifactorial etiology involving genetic, endocrine, metabolic, and environmental factors. Patients commonly present with menstrual irregularities, hyperandrogenism, infertility, obesity, and metabolic disturbances. Because symptoms may develop gradually and differ among patients, diagnosis is often delayed. Untreated PCOS may increase the risk of type 2 diabetes mellitus, cardiovascular disease, endometrial hyperplasia, and psychological disorders. Therefore, early diagnosis and appropriate management strategies are essential for reducing disease burden and improving quality of life.

The aim of this study was to assess the significance of early diagnosis in preventing complications of polycystic ovary syndrome and evaluate its impact on reproductive and metabolic outcomes.

The study included 100 women aged 18–35 years diagnosed with polycystic ovary syndrome according to established diagnostic criteria. Clinical examination, hormonal assessment, pelvic ultrasonography, and metabolic evaluation were performed. Parameters including menstrual history, body mass index, serum hormone levels, glucose metabolism, and reproductive outcomes were analyzed. Statistical methods were used to determine associations between early diagnosis and clinical outcomes.

The study demonstrated that women diagnosed at earlier stages of the disease showed improved menstrual regulation and better reproductive outcomes compared with patients diagnosed later. Early therapeutic interventions reduced the frequency of metabolic disturbances and improved hormonal balance. Patients receiving individualized treatment plans experienced better symptom control and lower rates of infertility-related complications. Early management also contributed to improvements in quality of life and psychological well-being.

Early diagnosis of polycystic ovary syndrome plays an important role in preventing long-term reproductive and metabolic complications. Comprehensive clinical evaluation and individualized treatment approaches contribute to improved health outcomes and better quality of life among women of reproductive age.

1. Azziz R., et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.

2. Teede H.J., et al. International evidence-based guideline for PCOS. Hum Reprod. 2018;33(9):1602–1618.

3. Escobar-Morreale H.F. Polycystic ovary syndrome. N Engl J Med. 2018;379:1343–1352.

4. Goodarzi M.O., Dumesic D.A., Chazenbalk G., Azziz R. Polycystic ovary syndrome. Endocr Rev. 2011;32(5):706–744.

5. med1.uz – Educational resources on gynecology and reproductive medicine.